This inventor holds 2 USPTO granted patents. Top assignees: Boehringer Ingelheim Gmbh, Boehringer Ingelheim International Gmbh. Active years: 2007-2009.
Company Filing History:
1 out of 306 
1 out of 1,560 
Years Active: 2007-2009
Title: Edith Pfitzner: Innovator in Tumor Disease Research
Introduction
Edith Pfitzner is a notable inventor based in Frankfurt, Germany. She has made significant contributions to the field of biomedical research, particularly in understanding tumor diseases and inflammatory airway diseases. With a total of 2 patents, her work focuses on innovative methods to identify substances that can modulate critical signaling pathways.
Latest Patents
Pfitzner's latest patents include a test system for measuring the interaction of STAT 6 with NCoA-1. This invention relates to a method for identifying substances that can modulate IL-4 dependent signaling involved in tumor diseases, specifically Hodgkin Lymphomas and asthma. Another significant patent is a method for determining whether a substance can modulate the interaction of STAT6 with NCoA-1, which is crucial for understanding IL-4 signaling.
Career Highlights
Throughout her career, Pfitzner has worked with prominent companies such as Boehringer Ingelheim GmbH and Boehringer Ingelheim International GmbH. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of medical research.
Collaborations
One of her notable collaborators is Claudia Monika Litterst, who has worked alongside Pfitzner in various research endeavors. Their partnership has contributed to advancements in understanding the mechanisms of tumor diseases.
Conclusion
Edith Pfitzner's contributions to biomedical research through her patents and collaborations highlight her role as an innovator in the field. Her work continues to pave the way for new treatments and understanding of complex diseases.